Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

about

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

Item

http://www.wikidata.org/entity/Q55015201

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

@en

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

@nl

type

Item

label

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

@en

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

@nl

prefLabel

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

@en

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds.

@nl

P1476

Three-years outcomes of diabetic patients treated with coronary bioresorbable scaffolds

@en

P2093

Helen Ullrich

http://www.w3.org/2001/XMLSchema#string

Katharina Schnitzler

http://www.w3.org/2001/XMLSchema#string

Liv Lorenz

http://www.w3.org/2001/XMLSchema#string

Melissa Weissner

http://www.w3.org/2001/XMLSchema#string

Thomas Münzel

http://www.w3.org/2001/XMLSchema#string

Tommaso Gori

http://www.w3.org/2001/XMLSchema#string

P2860

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Clinical end points in coronary stent trials: a case for standardized definitions.

Effects of stent sizing on endothelial and vessel wall stress: potential mechanisms for in-stent restenosis

Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.

Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study).

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial.

Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.

Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population.

High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry.

Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry).

P2888

s12872-018-0811-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12872-018-0811-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Polimeni

Remzi Anadol

P577

2018-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103904469

http://www.w3.org/2001/XMLSchema#string

P698

29743023

http://www.w3.org/2001/XMLSchema#string

P932

5944115

http://www.w3.org/2001/XMLSchema#string